A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of multiple sclerosis. The results are striking because existing MS treatments are designed to reduce future inflammatory attacks, not restore neurological function already lost.

A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard screening, identifying cancers that otherwise might have gone undetected until later stages, according to a new study from the Oregon Health & Science University Knight Cancer Institute.

Scientists at the University of Galway have taken part in a first-in-human study of stroke patients using a thin wire fitted with sensors to assess and map their clots.

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, led the development of a new investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable.

In the sickest COVID-19 patients, SARS-CoV-2 doesn’t just cause severe damage by directly infecting airway cells. The virus can also trigger hyperinflammation—a cycle in which immune cells themselves become infected, stop fighting the virus and instead trigger high levels of inflammation throughout the lungs.

Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast cancer spread to the brain and escape the body’s immune defenses.